Tests MRI-guided radiation for prostate cancer
Tests MRI-guided radiotherapy in adults with prostate cancer.
Plain-language title generated from the registry record
Registry title: Study of MR-based IGRT for Prostate Cancer
Key facts
- Where
- Tübingen, GermanySee the site
Where in Germany
- Müller Arndt-ChristianTübingen, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital Tuebingen
- Trial code
- NCT02724670
- Record updated
- 25 September 2019
- Original description
MR (Magnetic Resonance Imaging) - based IGRT (image-guided radiotherapy) for patients with prostate carcinoma.Read full original descriptionShow less
Single-arm Phase II Study of MR(Magnetic Resonance Imaging)-Based Image-guided Radiotherapy for Prostate Cancer
MR (Magnetic Resonance Imaging) - based IGRT (image-guided radiotherapy) for patients with prostate carcinoma.
Inclusion: histologically proven prostate cancer; indication for curative treatment; ECOG performance scale 0-2; Informed consent.
Exclusion: previous pelvic radiotherapy or prostatic treatment like TURP (transurethral resection of prostate), HIFU (high intensity focused ultrasound); serious comorbidity leading to inability for IGRT (image-guided radiotherapy); age<18year; contraindications for curative treatment; contraindications for MRI (Magnetic Resonance Imaging).